Skip Nav Destination
Issues
April 2022
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 0042-1138
EISSN 1423-0399
In this Issue
Urologia Internationalis 2022, Vol. 106, No. 4
Research Article
Predictive Factors in Sacral Neuromodulation: A Systematic Review
Subject Area:
Further Areas
Ranjana Jairam; Jamie Drossaerts; Tom Marcelissen; Gommert van Koeveringe; Desiree Vrijens; Philip van Kerrebroeck
Urol Int (2022) 106 (4): 323–343.
https://doi.org/10.1159/000513937
The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 344–351.
https://doi.org/10.1159/000517310
Hemostatic Agent May Improve Perioperative Outcomes in Partial Nephrectomy: A Systematic Review and Meta-Analysis
Subject Area:
Further Areas
Qiong Guo; Yifei Lin; Chenyang Zhang; Yi Guo; Youlin Long; Fangqun Leng; Juan Gao; Yifan Cheng; Liu Yang; Liang Du; Ga Liao; Jin Huang
Urol Int (2022) 106 (4): 352–359.
https://doi.org/10.1159/000518125
Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation
Subject Area:
Further Areas
Johannes Rückher; Jessica Lobitz; Markus Follmann; Steffi Derenz; Stefanie Schmidt; Jumana Mensah; Simone Wesselmann
Urol Int (2022) 106 (4): 360–367.
https://doi.org/10.1159/000517893
Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma
Subject Area:
Further Areas
Hiroki Ishihara; Hidekazu Tachibana; Hironori Fukuda; Kazuhiko Yoshida; Hirohito Kobayashi; Toshio Takagi; Junpei Iizuka; Hideki Ishida; Tsunenori Kondo; Kazunari Tanabe
Urol Int (2022) 106 (4): 368–375.
https://doi.org/10.1159/000518162
The Significance of INHBE Expression in the Cancer Cells of Clear-Cell Renal Cell Carcinoma
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 376–386.
https://doi.org/10.1159/000518161
Permanent Flank Bulge after Flank Incision: Patient- and Physician-Reported Outcome
Subject Area:
Further Areas
Jennifer Kranz; Sebastian Grundl; Friederike Wußow; Joachim Steffens; Petra Anheuser; Laila Schneidewind
Urol Int (2022) 106 (4): 387–396.
https://doi.org/10.1159/000517288
The Efficacy of Surgical Metastasectomy for Solitary Metastasis of Renal Cell Carcinoma
Subject Area:
Further Areas
Kotaro Suzuki; Takuto Hara; Tomoaki Terakawa; Junya Furukawa; Kenichi Harada; Nobuyuki Hinata; Yuzo Nakano; Masato Fujisawa
Urol Int (2022) 106 (4): 397–403.
https://doi.org/10.1159/000516679
Prospective Single-Center Study of SuperPulsed Thulium Fiber Laser in Retrograde Intrarenal Surgery: Initial Clinical Data
Subject Area:
Further Areas
Mark Taratkin; Camilla Azilgareeva; Dmitry Korolev; Yazeed Barghouthy; Dmitry Tsarichenko; Gagik Akopyan; Denis Chinenov; Stanislav Ali; Vasiliy Kozlov; Vasiliy Mikhailov; Dmitry Enikeev
Urol Int (2022) 106 (4): 404–410.
https://doi.org/10.1159/000516933
Prospective Evaluation of Antibiotic Management in Ureteral Stent and Nephrostomy Interventions
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 411–418.
https://doi.org/10.1159/000517546
Nephron-Sparing Surgery for Renal Cell Carcinoma with Tumor Thrombus
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 419–425.
https://doi.org/10.1159/000516697
Case Report
Primary Renal Synovial Sarcoma Case Series: Clinical Profile and Management of a Rare Entity
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 426–428.
https://doi.org/10.1159/000520223
Letter to the Editor
The Results of the Paper by Westhoff et al. “Prospective Evaluation of Antibiotic Management in Ureteral Stent and Nephrostomy Interventions” Should Encourage Proper Use of Antimicrobial Prophylaxis in Patients Undergoing Nephrostomy Tube Replacement
Subject Area:
Further Areas
Urol Int (2022) 106 (4): 429–430.
https://doi.org/10.1159/000520804
